Can Germany's ailing economy get back on trac...

GLP-1 weight-loss drugs such as Ozempic, Wegovy, Mounjaro and Zepbound are reshaping the treatment of obesity around the world. But even when these medicines are judged “cost-effective”, access often depends on who can afford to pay. In the second episode of our Business Daily se ...  Show more

GLP-1 weight-loss drugs such as Ozempic, Wegovy, Zepbound and Mounjaro are reshaping the treatment of obesity — and transforming the global pharmaceutical market.Originally developed to treat type-2 diabetes, these injectable medicines — including semaglutide and tirzepatide — ar ...  Show more

Germany’s economy is stagnating; households have less disposable income, and businesses report having less faith in the future. Once the growth engine of Europe, the country has gradually been losing its competitive edge. Now, economic anxieties have fuelled a political crisis th ...  Show more

When Chancellor Olaf Scholz fired his finance minister, Christian Lindner last month, Germany’s ‘traffic light’ government collapsed, an uneasy coalition between parties with differing perspectives and strained relations, the Social Democrats, the Greens and the Free Democrats.At ...  Show more

Germany's pivotal role in resolving the Eurozone crisis has sparked fierce international discussion but also deep rifts at home. Katya Adler speaks to Hans-Werner Sinn, one of Germany's most influential and controversial economists, who is at the heart of that debate. Recently he ...  Show more

For decades, Germany has relied on manufacturing and exports – a model that made it the world’s third largest economy. But that model is breaking down, and the country’s leaders are offering few alternatives in the upcoming election. WSJ’s Tom Fairless and Bertrand Benoit discuss ...  Show more